| Literature DB >> 26934734 |
Pu Lv1, Haiqiang Jin1, Yuanyuan Liu1, Wei Cui1, Qing Peng1, Ran Liu1, Wei Sun1, Chenghe Fan1, Yuming Teng1, Weiping Sun1, Yining Huang1.
Abstract
BACKGROUND: Stroke is the second most common cause of mortality in China. Although most subtypes of ischemic stroke share similar risk factors, they have different etiologies. Our study aimed to evaluate the different risk factor profiles between the stroke subtypes, lacunar infarcts (LI) and large-artery atherosclerosis (LAA), and clarify the characteristics of current acute ischemic stroke in China.Entities:
Mesh:
Substances:
Year: 2016 PMID: 26934734 PMCID: PMC4774914 DOI: 10.1371/journal.pone.0149605
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Characteristics of patients stratified by ischemic stroke (IS) subtype.
| Etiologic subtypes of IS | |||||
|---|---|---|---|---|---|
| All IS | LI | LAA | CE | UDI | |
| N | 1982 | 566(28.6%) | 1207(60.9%) | 173(8.7%) | 36(1.8%) |
| Male, N | 1299(65.5%) | 375(66.3%) | 824(68.3%) | 75(43.4%) | 25(69.4%) |
| Female, N | 683(34.5%) | 191(33.7%) | 383(31.7%) | 98(56.6%) | 11(30.6%) |
| Age, years | 67±13 | 69±12 | 66±13 | 70±10 | 46±7 |
Values are reported as mean±SD or n (%) of subjects.
IS: ischemic stroke; LI: lacunar infarct; LAA: large artery atherosclerosis; CE: cardioembolism; UDI: undetermined causes of infarction.
The clinical characteristics of LI patients and LAA patients.
| Variable | LAA (N = 1207) | LI (N = 566) | P value |
|---|---|---|---|
| Patients’ characteristics | |||
| Age, year | 66±13 | 69±12 | <0.001 |
| Male gender, n(%) | 824(68.3%) | 375(66.3%) | 0.402 |
| Risk factors | |||
| Diabetes, n(%) | 283(23.4%) | 191(33.7%) | <0.001 |
| Smoking, n(%) | 566(47.3%) | 251(44.5%) | 0.291 |
| Hypertension, n(%) | 644(53.3%) | 395(69.8%) | <0.001 |
| History of TIA/CVD, n(%) | 232(21.9%) | 134(24%) | 0.384 |
| History of CHD, n(%) | 261(21.8%) | 150(26.5%) | 0.033 |
| Alcohol abuse, n(%) | 458(38.4%) | 196(34.8%) | 0.159 |
| Anti-hypertensive drugs, n(%) | 628(52%) | 386(68.2%) | <0.001 |
| Anti-diabetic therapy, n(%) | 278(23%) | 189(33.4%) | <0.001 |
| Statin use, n(%) | 274(22.7%) | 144(25.4%) | 0.236 |
| Anti-platelet drugs, n(%) | 238(19.7%) | 173(30.6%) | <0.001 |
| Laboratory and imaging tests on admission | |||
| Systolic blood pressure mmHg | 143.5±21.33 | 141.10±19.70 | 0.041 |
| Diastolic blood pressure mmHg | 83.05±12.96 | 80.99±12.30 | 0.003 |
| Hemoglobin, g/L | 139.53±19.59 | 136.86±18.39 | 0.002 |
| Serum albumin, g/L | 39.37±4.92 | 39.70±5.14 | 0.408 |
| Serum creatinine, μmol/L | 98.90±52.59 | 98.75±47.44 | 0.695 |
| Triglyceride, mmol/L | 1.59±0.98 | 1.61±1.22 | 0.390 |
| Total cholesterol, mmol/L | 4.46±1.12 | 4.32±1.03 | 0.042 |
| HDL-c, mmol/L | 1.04±0.36 | 1.06±0.30 | 0.232 |
| LDL-c, mmol/L | 2.77±0.94 | 2.59±0.83 | 0.001 |
| Homocysteine, μmol/L | 17.93±42.78 | 17.16±10.69 | 0.064 |
| White matter leukoaraiosis, n(%) | 353(29.2%) | 223(39.4%) | <0.001 |
Values are reported as mean±SD or n (%) of subjects. Percentages based on nonmissing values: 2 missing value of sex; 8 (1) missing value of hypertension; 10 (1) missing value of diabetes; 11 (1) missing value of history of CHD; 149 (7) missing value of history of TIA/CVD; 11 (2) missing value of smoking; 15 (3) missing value of alcohol use; 221 (37) missing value of SBP and DBP, respectively; 178 (10) missing value of hemoglobin; 172 (12) missing value of serum albumin; 14 (5) missing value of serum creatinine; 178,179,180 and 183 (14, 13, 13 and 13) missing value of triglyceride, total cholesterol, HDL-c and LDL-c, respectively; and 400 (235) missing value of homocysteine; number in LAA (number in LI stroke)
LI: lacunar infarct; LAA: large artery atherosclerosis; CHD: coronary heart disease; CVD: cerebrovascular disease; TIA; transient ischemic attack; SBP: systolic blood pressure;DBP: diastolic blood pressure; LDL: low-density lipoprotein; HDL: high-density lipoprotein.
Results of univariate and multivariate logistic analysis: clinical characteristics associated with different stroke subtypes (LI patients vs. LAA patients).
| Variable | LI vs. LAA (N = 1773) | |||
|---|---|---|---|---|
| Unadjusted | Adjusted | |||
| OR (95%CI) | P | OR (95%CI) | P | |
| Male gender | 0.908(0.735, 1.124) | 0.372 | … | … |
| Hypertension | 2.022(1.638, 2.504) | <0.001 | 1.832(1.149, 2.977) | 0.012 |
| Diabetes | 1.664(1.336, 2.072) | <0.001 | 1.875(0.914, 4.064) | 0.096 |
| History of CHD | 1.295(1.026, 1.631) | 0.029 | 0.803(0.585, 1.096) | 0.170 |
| History of TIA/CVD | 1.123(0.879, 1.429) | 0.351 | … | … |
| Anti-hypertension drugs | 1.981(1.608, 2.446) | <0.001 | 0.861(0.513, 1.431) | 0.568 |
| Anti-diabetic therapy | 1.677(1.345, 2.089) | <0.001 | 0.789(0.369, 1.594) | 0.523 |
| Statin use | 1.158(0.917,1.460) | 0.213 | … | … |
| Anti-platelet drugs | 1.794(1.427,2.253) | <0.001 | 1.197(0.887, 1.610) | 0.238 |
| Smoking | 0.893(0.730, 1.091) | 0.268 | … | … |
| Alcohol abuse | 0.856(0.694, 1.054) | 0.145 | 0.800(0.593, 1.076) | 0.141 |
| Age | 1.019(1.011, 1.027) | <0.001 | 1.004(0.991, 1.017) | 0.538 |
| Systolic blood pressure | 0.995(0.989, 1.000) | 0.038 | 0.993(0.984, 1.001) | 0.091 |
| Diastolic blood pressure | 0.987(0.979, 0.996) | 0.003 | 0.996(0.982, 1.011) | 0.621 |
| Hemoglobin | 0.993(0.988, 0.998) | 0.009 | 1.002(0.994, 1.009) | 0.691 |
| Serum albumin | 1.013(0.992, 1.034) | 0.219 | … | … |
| Serum creatinine | 1.001(0.999, 1.004) | 0.343 | … | … |
| Triglyceride | 1.021(0.926, 1.123) | 0.674 | … | … |
| Total cholesterol | 0.884(0.802, 0.973) | 0.012 | 0.922(0.829, 1.023) | 0.130 |
| HDL-c | 1.160(0.858, 1.593) | 0.334 | … | … |
| LDL-c | 0.790(0.701, 0.889) | <0.001 | 0.774(0.658, 0.908) | 0.002 |
| Homocysteine | 0.999(0.993, 1.003) | 0.752 | … | … |
| WML | 1.575(1.277, 1.941) | <0.001 | 1.865(1.390, 2.505) | <0.001 |
Adjusted odds ratio (OR) models were adjusted for Hypertension, Diabetes, History of CHD, Anti-hypertension drugs, Anti-diabetic therapy, Anti-platelet drugs, Alcohol abuse, Age, SBP, DBP, Hemoglobin, LDL-c, WML in multiple logistic analyses
* Adjusted odds ratio (OR) models were adjusted for Hypertension, Diabetes, History of CHD, Anti-hypertension drugs, Anti-diabetic therapy, Anti-platelet drugs, Alcohol abuse, Age, SBP, DBP, Hemoglobin, WML in multivariate logistic analyses.